Tuberculosis

Share
Share this

One-third of the world’s population is currently infected with the TB bacillus but they have a latent form of the disease and so have no symptoms and cannot transmit it. In some people, the latent TB infection progresses to acute TB, often due to a weak immune system. Every year, about nine million people develop active TB and 1.5 million die from it.

TB is spread through the air when infected people cough or sneeze. Not everyone infected with TB becomes ill, but 10 per cent will develop active TB at some point in their lives. The disease most often affects the lungs. Symptoms include a persistent cough, fever, weight loss, chest pain and breathlessness in the lead-up to death. TB incidence is much higher, and is a leading cause of death, among people with HIV.

Diagnosis of TB depends on a sputum or gastric fluid sample, which can be difficult to obtain from children. A new molecular test that can give results after just two hours and detect a certain level of drug resistance is now being used, but it is costly and still requires a phlegm sample, as well as a reliable power supply.

A course of treatment for uncomplicated TB takes a minimum of six months. When patients are resistant to the two most powerful first-line antibiotics (isoniazid and rifampicin), they are considered to have multidrug-resistant TB (MDR-TB). MDR-TB is not impossible to treat, but the drug regimen is arduous, taking up to two years and causing many side effects. Extensively drug-resistant tuberculosis (XDR-TB) is identified when patients show resistance to the second-line drugs administered for MDR-TB. The treatment options for XDR-TB are very limited.

In 2014, MSF treated 21,500 patients for TB, of which 1,800 for MDR-TB.

Vacancy
Médecins Sans Frontières (MSF), an international medical humanitarian organisation created in 1971...
Updates
Article
Since 2014, deteriorating security, explosive devices on roads and the risk of carjacking have...
Press release
Not enough is being done to ensure people on antiretroviral treatment (ART) reach and maintain ‘...
Op-ed
"Development aid medicine will not work if the prescription is based on a faulty diagnosis" says...
Patient story
"When I was put on this new drug regimen I gained hope that I could be cured. I became cheerful and...
Updates
MSF says a new combination of drugs created to treat extensively drug-resistant TB (XDR-TB) is...
Interview
Testimony
"MSF’s work has had a massive impact in bridging the gap in healthcare since the beginning of the...
Interview
In 2014, MSF carried out more than 63, 140 consultations, treated over 15,274 patients of malaria,...
Medical publications
PLOS Medicine paper on the need for a preparedness R&D mechanism that can quickly deliver...
Press release
A new survey released by Stop Stock Outs Project shows that shortages of essential HIV and...
Testimony
"When I arrived at my clinic, I was told that my treatment was not in stock and sent home with no...
Vacancy
Regional Advocacy Manager for our TB programs in Central Asia Looking for new professional...
Month in Focus
SYRIA – A humanitairan failure EBOLA - Remain vigilant ETHIOPIA – The plight of women refugees MDR-...
Photo of the week
Tuberculosis (TB) is a big problem in eastern Ukraine , especially in prisons. The official death...
Press release
Urges leadership in all European countries to commit to sending high-level political representation...
Video
Ignored for the past fifty years, the needs of patients suffering from tuberculosis are finally...

Pages